Alejandro Alvaro Meca-rekin lankidetzan egindako argitalpenak (12)

2022

  1. Effectiveness of an HIV care model integrated into addiction care based on medication-assisted treatment for HIV-positive people who use drugs

    AIDS Care - Psychological and Socio-Medical Aspects of AIDS/HIV, Vol. 34, Núm. 10, pp. 1297-1304

  2. Neighborhood environmental factors linked to hospitalizations of older people for viral lower respiratory tract infections in Spain: a case-crossover study

    Environmental Health: A Global Access Science Source, Vol. 21, Núm. 1

2021

  1. Recurring Severe Injection-Related Infections in People Who Inject Drugs and the Need for Safe Injection Sites in Madrid, Spain

    Open Forum Infectious Diseases, Vol. 8, Núm. 7

2020

  1. Epidemiological trend of hepatitis C-related liver events in Spain (2000–2015): A nationwide population-based study

    European Journal of Internal Medicine, Vol. 75, pp. 84-92

  2. Epidemiological trend of sepsis in patients with hospital admissions related to hepatitis C in Spain (2000–2015): A nationwide study

    Journal of Clinical Medicine, Vol. 9, Núm. 6

  3. Gender-based vulnerability in women who inject drugs in a harm reduction setting

    PLoS ONE, Vol. 15, Núm. 3

2019

  1. High rates of early HCV reinfection after DAA treatment in people with recent drug use attended at mobile harm reduction units

    International Journal of Drug Policy, Vol. 72, pp. 181-188

  2. National temporal trend analysis of infective endocarditis among patients infected with HIV in Spain (1997–2014): A retrospective study

    Journal of Clinical Medicine, Vol. 8, Núm. 8

2018

  1. Epidemiological trends of deep venous thrombosis in HIV-infected subjects (1997–2013): A nationwide population-based study in Spain

    European Journal of Internal Medicine, Vol. 48, pp. 69-74

  2. HCV seroconversion in a cohort of people who use drugs followed in a mobile harm reduction unit in Madrid: Breaking barriers for HCV elimination

    PLoS ONE, Vol. 13, Núm. 10

  3. High HIV seroconversion rate in hepatitis C virus-infected drug users followed in a harm reduction unit: A lost opportunity for preexposure prophylaxis

    AIDS, Vol. 32, Núm. 9, pp. 1157-1163

  4. Trends in pulmonary embolism in patients infected with HIV during the combination antiretroviral therapy era in Spain: A nationwide population-based study

    Scientific Reports, Vol. 8, Núm. 1